Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies.

Psychiatry research - 1 Dec 2021

De Pol Michelle, Kolla Nathan J

Abstract excerpt

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social communication deficits and patterns of restrictive and repetitive behavior. Although the neurological underpinnings of ASD remain elusive, the endocannabinoid system (ECS) may play a role in modulating social behavior in ASD. Preclinical studies have suggested that alterations in the ECS result in ASD-like phenotypes, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder
Share to Biomarkers
Share to Endocannabinoids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Social Behavior

Source

Identifiers

PMID: 34775294
DOI: 10.1016/j.psychres.2021.114256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies.PMID 34775294Read ↗

Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing StudiesSemantic proximity Read ↗

The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies.Semantic proximity Read ↗

Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.Semantic proximity Read ↗

Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.Semantic proximity Read ↗

Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acidSemantic proximity Read ↗

Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label studySemantic proximity Read ↗

Pharmacological Interventions in Autism Spectrum Disorder: A Comprehensive Review of Mechanisms and EfficacySemantic proximity Read ↗

Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders.Semantic proximity Read ↗

Cannabidiol-Induced Recovery of Social Behaviour in Mouse Models of Syndromic AutismSemantic proximity Read ↗

Cannabidiol-Induced Recovery of Social Behaviour in Mouse Models of Syndromic AutismSemantic proximity Read ↗

Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies.Semantic proximity Read ↗

Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.